[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Tab Hydroxycholoroquine on day 1 followed by 400 mg OD for 5 days: the efficacy of HCQ as treatment for mild COVID-19 with high risk will be elucidated.the safety of HCQ as treatment for mild COVID-19 with high risk characteristics will be addressed .Intervention2: Tab Hydroxychloroquine (HCQ)400 mg BD on day 1 followed by 400 mg OD for total 5 days: Hydroxychloroquine (HCQ); sold under the brand name Plaquenil among others; is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquineommon side effects include vomiting; headache; changes in vision; and muscle weaknessIntervention3: HYDROOXYCHLOROQUINE: HCQ 400 MG BD ON DAY 1 FOLLOWED BY 400 MG OD FOR TOTAL 5 DAYSControl Intervention1: SYMPTOMATIC TREATMENT: CONTROL GROUP WILL RECEIVE SYMPTOMATIC TREATMENT which includes paracetamol and other drugs according to symptoms.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Tab Hydroxycholoroquine on day 1 followed by 400 mg OD for 5 days: the efficacy of HCQ as treatment for mild COVID-19 with high risk will be elucidated.the safety of HCQ as treatment for mild COVID-19 with high risk characteristics will be addressed .", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention2: Tab Hydroxychloroquine (HCQ)400 mg BD on day 1 followed by 400 mg OD for total 5 days: Hydroxychloroquine (HCQ); sold under the brand name Plaquenil among others; is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquineommon side effects include vomiting; headache; changes in vision; and muscle weakness", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention3: HYDROOXYCHLOROQUINE: HCQ 400 MG BD ON DAY 1 FOLLOWED BY 400 MG OD FOR TOTAL 5 DAYS", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: SYMPTOMATIC TREATMENT: CONTROL GROUP WILL RECEIVE SYMPTOMATIC TREATMENT which includes paracetamol and other drugs according to symptoms.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": 607, "treatment_name": "Hydroxychloroquine", "treatment_type": "Antimalarials", "pharmacological_treatment": "Pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2188, "treatment_name": "Standard of care", "treatment_type": "Standard of care", "pharmacological_treatment": "Standard of care"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "N/A", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]

[{"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Tab Hydroxycholoroquine on day 1 followed by 400 mg OD for 5 days: the efficacy of HCQ as treatment for mild COVID-19 with high risk will be elucidated.the safety of HCQ as treatment for mild COVID-19 with high risk characteristics will be addressed .Intervention2: Tab Hydroxychloroquine (HCQ)400 mg BD on day 1 followed by 400 mg OD for total 5 days: Hydroxychloroquine (HCQ); sold under the brand name Plaquenil among others; is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquineommon side effects include vomiting; headache; changes in vision; and muscle weaknessIntervention3: HYDROOXYCHLOROQUINE: HCQ 400 MG BD ON DAY 1 FOLLOWED BY 400 MG OD FOR TOTAL 5 DAYSControl Intervention1: SYMPTOMATIC TREATMENT: CONTROL GROUP WILL RECEIVE SYMPTOMATIC TREATMENT which includes paracetamol and other drugs according to symptoms.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention1: Tab Hydroxycholoroquine on day 1 followed by 400 mg OD for 5 days: the efficacy of HCQ as treatment for mild COVID-19 with high risk will be elucidated.the safety of HCQ as treatment for mild COVID-19 with high risk characteristics will be addressed .", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention2: Tab Hydroxychloroquine (HCQ)400 mg BD on day 1 followed by 400 mg OD for total 5 days: Hydroxychloroquine (HCQ); sold under the brand name Plaquenil among others; is a medication used to prevent and treat malaria in areas where malaria remains sensitive to chloroquineommon side effects include vomiting; headache; changes in vision; and muscle weakness", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Intervention3: HYDROOXYCHLOROQUINE: HCQ 400 MG BD ON DAY 1 FOLLOWED BY 400 MG OD FOR TOTAL 5 DAYS", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}, {"arm_notes": "", "treatment_id": null, "treatment_name": "Control Intervention1: SYMPTOMATIC TREATMENT: CONTROL GROUP WILL RECEIVE SYMPTOMATIC TREATMENT which includes paracetamol and other drugs according to symptoms.", "treatment_type": "TODO", "pharmacological_treatment": "TODO"}]